The Impact on Health Outcomes and Healthcare Utilisation of Switching to Generic Medicines Consequent to Reference Pricing: The Case of Lamotrigine in New Zealand

Switching from brand to generic lamotrigine is largely devoid of adverse health outcomes; however, creating an incentive to ensure a greater proportion of patients switch to generic lamotrigine is required to achieve maximal financial savings from a policy of generic reference pricing. </AbstractSection> Copyright Springer International Publishing Switzerland 2014

MoreLess

Year of publication:	2014
Authors:	Lessing, Charon ; Ashton, Toni ; Davis, Peter
Published in:	Applied Health Economics and Health Policy. - Springer, ISSN 1175-5652. - Vol. 12.2014, 5, p. 537-546
Publisher:	Springer

Online Resource

Check full text access |

More access options

Check Google Scholar

In libraries world-wide (WorldCat)

In German libraries (KVK)

subito order

I need help

More details

Extent:	text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10011000692